5
Total deals
$1.6B
Total value
$388.1M
Avg deal
$704.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Optimer Pharmaceuticals
Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused o…
|
2013-07-30 | Acquisition | Complete | $535.0M | Deal → |
| 2 |
Trius Therapeutics
Trius Therapeutics is focused on the development of innovative antibiotics for l…
|
2013-07-30 | Acquisition | Complete | $704.0M | Deal → |
| 3 |
Adolor
Adolor focuses on the discovery, development and commercialization of prescripti…
|
2011-10-14 | Acquisition | Complete | $221.0M | Deal → |
| 4 |
Calixa Therapeutics
Calixa Therapeutics, a biopharmaceutical company, develops a novel cephalosporin…
|
2009-12-14 | Acquisition | Complete | $92.5M | Deal → |
| 5 |
Illumigen Biosciences
Illumigen Biosciences is drug discovery and development firm.
|
2007-12-24 | Merge | Complete | — | Deal → |